Drug Standards
Medchemexpress LLC Zileuton | 111406-87-2 | MFCD00866097 | 99.6% | C11H12N2O2S | 100 MG
Zileuton is a potent and selective inhibitor of 5-lipoxygenase with antiasthmatic properties, intended for research use only.
- Potent and selective inhibitor of 5-lipoxygenase
- Has antiasthmatic properties
- Available as a solid
- Melting point is 157-158°C
- Stable under recommended storage conditions
- Identified for laboratory chemical uses
U.S. Pharmacopeia CAPROLACTAM (1 G)
U S PHARMACOPEIA/ Caprolactam / (1 g) / CAS No.:105-60-2 / Caprolactam
Medchemexpress LLC S-diclofenac | 912758-00-0 | 99.2% | 504.47 g/mol | C23H15Cl2NO2S3 | 10 MG
S-diclofenac is a hybrid molecule that combines an H2S donor with the nonsteroidal anti-inflammatory scaffold of diclofenac. It shows multifaceted biological activity including activation of the p53 signaling pathway, inhibition of JNK, antioxidant effects, and anti-inflammatory activity, and has been used in both in vitro and in vivo research models to study inflammation, oxidative stress, and cardiac injury.
- Activates the p53 signaling pathway and upregulates downstream effectors.
- Inhibits JNK activation, modulating stress-related signaling.
- Exhibits antioxidant and anti-inflammatory properties.
- Demonstrates efficacy in animal models of edema and myocardial injury.
- Provided at high listed purity to support research reproducibility.
- Available as small solid packages and as a solution in DMSO for convenience.
- Solid appearance described as reddish brown to red.
Sigma Aldrich Fine Chemicals Biosciences Beclomethasone dipropionate anhydrous, European Pharmacopoeia (EP) Reference Standard | 5534-09-8 | MFCD00135613 |
Beclomethasone dipropionate anhydrous, European Pharmacopoeia (EP) Reference Standard | Mol Wt: 521.04 | 5534-09-8 | MFCD00135613 |
Sigma Aldrich Fine Chemicals Biosciences L-(−)-Fucose | 2438-80-4 | MFCD00135607 | 5g
L-(−)-Fucose | Purity: 99% | MW: 164.16 | 2438-80-4 | MFCD00135607 | 5g
Medchemexpress LLC Crizotinib | 877399-52-5 | 99.97% | C21H22Cl2FN5O | 1 ML
Crizotinib is an orally bioavailable, ATP-competitive inhibitor of ALK, c-Met, and ROS1. It inhibits tyrosine phosphorylation in cell-based assays and demonstrates effective tumor growth inhibition. This product is for research use only.
- Orally bioavailable ALK, c-Met, and ROS1 inhibitor
- Inhibits tyrosine phosphorylation of NPM-ALK and c-Met
- Demonstrates effective tumor growth inhibition
- Powder storage: -20°C for 3 years; 4°C for 2 years
- In-solvent storage: -80°C for 1 year; -20°C for 6 months
TARGETMOL CHEMICALS INC RUXOLITINIB 50MG
Also available in 5 mg 10 mg 25 mg 100 mg 200 mg 500 mg 1000 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Ruxolitinib (INCB018424) is a potent and selective JAK1/2 inhibitor (IC50 3.3/2.8 nM) and is relatively less selective for JAK3 (IC50 322 nM). purity: 99%
Apexbio Technology LLC Fluvoxamine 54739-18-3 50mg
Fluvoxamine (CAS 54739-18-3) is an antidepressant small molecule that functions primarily by selectively inhibiting serotonin (5-HT) reuptake In vitro studies have shown its ability to inhibit 5-HT uptake in platelets and brain synaptosomes In animal models fluvoxamine administration elevates extracellular serotonin levels across various brain regions and in combination with quetiapine also elevates dopamine levels in specific areas including prefrontal cortex and thalamus Additionally fluvoxamine modulates synaptic plasticity and displays potential analgesic effects mediated via serotonin receptor subtypes (5-HT1A 5-HT2A/2C and 5-HT3) Due to this pharmacological profile fluvoxamine serves as a valuable tool in neurological and psychiatric research